Shares of drug firm Wockhardt are in action even as the benchmark indices declined in early trade on Tuesday, December 2, 2025, amid uncertainty over repo rate cuts. The counter opened in green at Rs ...
China NMPA accepts and grants priority review status to Hutchmed’s NDA for fanregratinib in second-line intrahepatic cholangiocarcinoma: Hong Kong, Shanghai Wednesday, December ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback